Publicaciones en colaboración con investigadores/as de University of Cambridge (35)

2024

  1. Author Correction: Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement (Nature Reviews Endocrinology, (2023), 19, 12, (722-740), 10.1038/s41574-023-00886-5)

    Nature Reviews Endocrinology

2023

  1. Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement

    Nature Reviews Endocrinology, Vol. 19, Núm. 12, pp. 722-740

  2. Diminishing benefits of urban living for children and adolescents’ growth and development

    Nature, Vol. 615, Núm. 7954, pp. 874-883

2022

  1. Kappa-Opioid Receptor Blockade Ameliorates Obesity Caused by Estrogen Withdrawal via Promotion of Energy Expenditure through mTOR Pathway

    International Journal of Molecular Sciences, Vol. 23, Núm. 6

  2. Proceedings of the annual meeting of the European Consortium of Lipodystrophies (ECLip) Cambridge, UK, 7–8 April 2022

    Annales d'Endocrinologie

2021

  1. Consensus on diagnosis and management of Cushing's disease: a guideline update

    The lancet. Diabetes & endocrinology, Vol. 9, Núm. 12, pp. 847-875

  2. Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight

    eLife, Vol. 10

  3. Pituitary Neoplasm Nomenclature Workshop: Does Adenoma Stand the Test of Time?

    Journal of the Endocrine Society, Vol. 5, Núm. 3

  4. Sirt3 in POMC neurons controls energy balance in a sex- and diet-dependent manner

    Redox Biology, Vol. 41

2020

  1. A consensus on the diagnosis and treatment of acromegaly comorbidities: An update

    Journal of Clinical Endocrinology and Metabolism, Vol. 105, Núm. 4, pp. E937-E946

  2. European lipodystrophy registry: Background and structure

    Orphanet Journal of Rare Diseases, Vol. 15, Núm. 1

  3. Metabolic recovery after weight loss surgery is reflected in serum microRNAs

    BMJ Open Diabetes Research and Care, Vol. 8, Núm. 2

  4. Multidisciplinary management of acromegaly: A consensus

    Reviews in Endocrine and Metabolic Disorders, Vol. 21, Núm. 4, pp. 667-678

  5. PET-guided repeat transsphenoidal surgery for previously deemed unresectable lateral disease in acromegaly

    Neurosurgical Focus, Vol. 48, Núm. 6

2019

  1. Data on hyper-activation of GPVI signalling in obese patients: Towards the identification of novel antiplatelet targets in obesity

    Data in Brief

  2. GPVI surface expression and signalling pathway activation are increased in platelets from obese patients: Elucidating potential anti-atherothrombotic targets in obesity

    Atherosclerosis, Vol. 281, pp. 62-70

  3. Long-term effectiveness and safety of metreleptin in the treatment of patients with partial lipodystrophy

    Endocrine, Vol. 64, Núm. 3, pp. 500-511

  4. MCH regulates SIRT1/FoxO1 and reduces POMC neuronal activity to induce hyperphagia, adiposity, and glucose intolerance

    Diabetes, Vol. 68, Núm. 12, pp. 2210-2222

  5. Modern imaging of pituitary adenomas

    Best Practice and Research: Clinical Endocrinology and Metabolism, Vol. 33, Núm. 2

  6. Rising rural body-mass index is the main driver of the global obesity epidemic in adults

    Nature